CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 27 enrolled
Drug / intervention
Clopidogreldrug
Likely dose
Clopidogrel 300 mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00644657
NCT00644657N/ACompleted
CompareCT.gov

The Effect of Clopidogrel on Coated-Platelets in Patients Undergoing Cardiac Catheterization

University of Oklahoma·interventional·Posted Mar 27, 2008·Updated Oct 7, 2011

In Brief

A clinical study evaluating Clopidogrel for Coronary Artery Disease and Chest Pain. Completed, enrolled 27 participants across 1 site.

Detailed Summary

This study will explore the effect of clopidogrel on coated-platelets in patients who are given a loading dose before diagnostic catheterization or percutaneous coronary intervention. We hypothesis that clopidogrel will reduce the percentage of platelets that are coated and therefore more hypercoagulable.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCoronary Artery Disease, Chest Pain
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedMar 27, 2008
Enrollment StartMar 1, 2007
Primary CompletionSep 1, 2008
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 18.3 years ago

Interventions

Clopidogreldrug

All subjects will receive a 300 mg loading dose